Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RANK Ligand | 3 | 2016 | 326 | 1.020 |
Why?
|
| Tissue Scaffolds | 10 | 2023 | 956 | 0.630 |
Why?
|
| Ileum | 2 | 2016 | 565 | 0.560 |
Why?
|
| Microfluidics | 5 | 2023 | 662 | 0.550 |
Why?
|
| Vaccines | 4 | 2017 | 822 | 0.520 |
Why?
|
| Gelatin | 5 | 2023 | 225 | 0.490 |
Why?
|
| Methacrylates | 3 | 2022 | 107 | 0.440 |
Why?
|
| Chitosan | 3 | 2018 | 141 | 0.400 |
Why?
|
| Lab-On-A-Chip Devices | 3 | 2021 | 428 | 0.390 |
Why?
|
| Osteoclasts | 1 | 2014 | 729 | 0.360 |
Why?
|
| Alginates | 3 | 2023 | 252 | 0.360 |
Why?
|
| Tissue Engineering | 9 | 2023 | 1880 | 0.350 |
Why?
|
| Nanoparticles | 5 | 2021 | 1905 | 0.290 |
Why?
|
| Methylcellulose | 2 | 2016 | 37 | 0.280 |
Why?
|
| Immunization | 3 | 2018 | 1256 | 0.240 |
Why?
|
| Hydrogels | 7 | 2023 | 724 | 0.240 |
Why?
|
| Nanofibers | 2 | 2021 | 66 | 0.230 |
Why?
|
| Hepatocytes | 2 | 2023 | 1211 | 0.220 |
Why?
|
| Bacterial Vaccines | 2 | 2016 | 403 | 0.220 |
Why?
|
| Fibroins | 1 | 2023 | 55 | 0.220 |
Why?
|
| Escherichia coli | 1 | 2014 | 4217 | 0.200 |
Why?
|
| Side-Population Cells | 1 | 2021 | 12 | 0.200 |
Why?
|
| Peyer's Patches | 3 | 2016 | 121 | 0.200 |
Why?
|
| Drug Carriers | 2 | 2017 | 693 | 0.200 |
Why?
|
| Biocompatible Materials | 3 | 2021 | 1736 | 0.190 |
Why?
|
| RNA, Small Interfering | 3 | 2015 | 3505 | 0.190 |
Why?
|
| Gene Transfer Techniques | 3 | 2015 | 1224 | 0.190 |
Why?
|
| Hernia, Abdominal | 1 | 2021 | 53 | 0.190 |
Why?
|
| Hemorheology | 1 | 2021 | 145 | 0.190 |
Why?
|
| Polyethylene Glycols | 2 | 2016 | 1182 | 0.180 |
Why?
|
| Polyesters | 1 | 2021 | 363 | 0.170 |
Why?
|
| Cellulose | 1 | 2019 | 121 | 0.170 |
Why?
|
| Lithocholic Acid | 2 | 2016 | 27 | 0.170 |
Why?
|
| Inulin | 1 | 2018 | 84 | 0.160 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2019 | 102 | 0.160 |
Why?
|
| Tomography, Optical | 1 | 2019 | 126 | 0.160 |
Why?
|
| Foreign-Body Reaction | 1 | 2019 | 157 | 0.160 |
Why?
|
| Pulmonary Alveoli | 1 | 2021 | 675 | 0.160 |
Why?
|
| Administration, Oral | 5 | 2016 | 3913 | 0.150 |
Why?
|
| Immunity, Mucosal | 2 | 2017 | 490 | 0.150 |
Why?
|
| Actinobacillus Infections | 1 | 2016 | 16 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 5 | 2016 | 6386 | 0.140 |
Why?
|
| Biosensing Techniques | 1 | 2023 | 668 | 0.140 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2019 | 578 | 0.140 |
Why?
|
| Hemolysin Proteins | 1 | 2016 | 113 | 0.140 |
Why?
|
| Mannans | 1 | 2016 | 63 | 0.140 |
Why?
|
| Lactococcus lactis | 1 | 2015 | 28 | 0.140 |
Why?
|
| Transcytosis | 1 | 2016 | 44 | 0.140 |
Why?
|
| Nanocapsules | 1 | 2016 | 91 | 0.130 |
Why?
|
| Endocytosis | 3 | 2015 | 985 | 0.130 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2021 | 828 | 0.130 |
Why?
|
| Needles | 1 | 2018 | 449 | 0.130 |
Why?
|
| Galactose | 1 | 2016 | 306 | 0.130 |
Why?
|
| Immunoglobulin A | 2 | 2016 | 992 | 0.130 |
Why?
|
| Drug Delivery Systems | 3 | 2015 | 2219 | 0.130 |
Why?
|
| Receptors, N-Acetylglucosamine | 1 | 2014 | 10 | 0.130 |
Why?
|
| Vaccines, Subunit | 1 | 2015 | 168 | 0.130 |
Why?
|
| Polyethyleneimine | 1 | 2015 | 63 | 0.120 |
Why?
|
| Probiotics | 2 | 2018 | 351 | 0.120 |
Why?
|
| Particle Size | 2 | 2016 | 1642 | 0.120 |
Why?
|
| Actinobacteria | 1 | 2014 | 56 | 0.120 |
Why?
|
| Polyamines | 1 | 2014 | 120 | 0.120 |
Why?
|
| Fatty Liver | 1 | 2020 | 727 | 0.120 |
Why?
|
| Glycerol | 1 | 2015 | 278 | 0.120 |
Why?
|
| Acetylglucosamine | 1 | 2014 | 191 | 0.110 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2015 | 404 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2021 | 1376 | 0.110 |
Why?
|
| Peptide Fragments | 2 | 2015 | 5097 | 0.100 |
Why?
|
| Codon | 1 | 2014 | 611 | 0.100 |
Why?
|
| Transfection | 3 | 2015 | 5892 | 0.100 |
Why?
|
| Endosomes | 1 | 2015 | 520 | 0.100 |
Why?
|
| Antiviral Agents | 2 | 2021 | 2987 | 0.100 |
Why?
|
| Bone Resorption | 1 | 2016 | 723 | 0.100 |
Why?
|
| Bacterial Proteins | 2 | 2016 | 3848 | 0.100 |
Why?
|
| Cell Count | 1 | 2016 | 1856 | 0.100 |
Why?
|
| Animals | 20 | 2023 | 168757 | 0.100 |
Why?
|
| Surgical Wound Infection | 1 | 2021 | 1540 | 0.100 |
Why?
|
| Antibody Formation | 1 | 2016 | 1402 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 1351 | 0.100 |
Why?
|
| Flow Cytometry | 3 | 2016 | 5974 | 0.090 |
Why?
|
| Eye Proteins | 1 | 2014 | 646 | 0.090 |
Why?
|
| Lipoproteins | 1 | 2015 | 878 | 0.090 |
Why?
|
| Anti-Infective Agents | 1 | 2018 | 972 | 0.090 |
Why?
|
| Adjuvants, Immunologic | 1 | 2015 | 1000 | 0.090 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2016 | 986 | 0.090 |
Why?
|
| Antigens | 1 | 2016 | 1466 | 0.090 |
Why?
|
| Liver Neoplasms | 2 | 2016 | 4253 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 7181 | 0.090 |
Why?
|
| Monocytes | 1 | 2019 | 2596 | 0.090 |
Why?
|
| RNA Interference | 2 | 2015 | 2889 | 0.080 |
Why?
|
| Immunologic Memory | 1 | 2016 | 1348 | 0.080 |
Why?
|
| Cell Adhesion | 1 | 2015 | 3144 | 0.080 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2014 | 1122 | 0.080 |
Why?
|
| Cell Survival | 4 | 2021 | 5882 | 0.080 |
Why?
|
| Cell Line | 4 | 2016 | 15997 | 0.080 |
Why?
|
| Lymphocytes | 1 | 2016 | 2617 | 0.080 |
Why?
|
| Mice | 11 | 2023 | 81183 | 0.080 |
Why?
|
| Polymers | 4 | 2015 | 1621 | 0.080 |
Why?
|
| Intestinal Mucosa | 2 | 2015 | 3036 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2016 | 11483 | 0.080 |
Why?
|
| Immunoglobulin G | 2 | 2016 | 4560 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2016 | 4217 | 0.070 |
Why?
|
| Gene Expression | 2 | 2015 | 7799 | 0.070 |
Why?
|
| Respiratory Mucosa | 2 | 2021 | 427 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 4042 | 0.060 |
Why?
|
| Vaccination | 1 | 2017 | 3278 | 0.060 |
Why?
|
| Lymphocyte Activation | 1 | 2016 | 5524 | 0.060 |
Why?
|
| Models, Biological | 1 | 2021 | 9583 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2016 | 3474 | 0.060 |
Why?
|
| Drug Stability | 2 | 2014 | 291 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 13102 | 0.060 |
Why?
|
| Multiple Myeloma | 1 | 2021 | 5181 | 0.060 |
Why?
|
| Materials Testing | 2 | 2018 | 867 | 0.060 |
Why?
|
| DNA | 2 | 2015 | 7301 | 0.060 |
Why?
|
| Microspheres | 2 | 2016 | 777 | 0.060 |
Why?
|
| Ink | 1 | 2023 | 44 | 0.050 |
Why?
|
| Silk | 1 | 2023 | 91 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2214 | 0.050 |
Why?
|
| Semiconductors | 1 | 2023 | 105 | 0.050 |
Why?
|
| Caco-2 Cells | 1 | 2021 | 387 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10481 | 0.050 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 16689 | 0.050 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2021 | 149 | 0.050 |
Why?
|
| Electrodes | 1 | 2023 | 619 | 0.050 |
Why?
|
| Humans | 24 | 2023 | 744343 | 0.050 |
Why?
|
| Equipment Design | 2 | 2019 | 3582 | 0.050 |
Why?
|
| Porosity | 1 | 2021 | 362 | 0.050 |
Why?
|
| Models, Structural | 1 | 2020 | 361 | 0.040 |
Why?
|
| Macrophages | 1 | 2014 | 5655 | 0.040 |
Why?
|
| Rats | 3 | 2021 | 24260 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2021 | 677 | 0.040 |
Why?
|
| Paper | 1 | 2019 | 85 | 0.040 |
Why?
|
| Liver | 1 | 2015 | 7474 | 0.040 |
Why?
|
| Drug Repositioning | 1 | 2021 | 229 | 0.040 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 3586 | 0.040 |
Why?
|
| Nanomedicine | 1 | 2021 | 304 | 0.040 |
Why?
|
| Neoplasms | 2 | 2019 | 21683 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2021 | 1341 | 0.040 |
Why?
|
| Deoxycytidine | 1 | 2021 | 826 | 0.040 |
Why?
|
| Viral Envelope Proteins | 1 | 2021 | 635 | 0.040 |
Why?
|
| Actinobacillus pleuropneumoniae | 1 | 2016 | 8 | 0.040 |
Why?
|
| Adhesiveness | 1 | 2016 | 53 | 0.040 |
Why?
|
| Urothelium | 1 | 2018 | 277 | 0.030 |
Why?
|
| Listeria monocytogenes | 1 | 2018 | 250 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 713 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11524 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2021 | 1072 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2021 | 1686 | 0.030 |
Why?
|
| Acrylic Resins | 1 | 2015 | 142 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 6622 | 0.030 |
Why?
|
| Buffers | 1 | 2015 | 147 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 446 | 0.030 |
Why?
|
| Pigments, Biological | 1 | 2014 | 53 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 2016 | 298 | 0.030 |
Why?
|
| Hexuronic Acids | 1 | 2014 | 144 | 0.030 |
Why?
|
| Glucuronic Acid | 1 | 2014 | 148 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2014 | 12208 | 0.030 |
Why?
|
| Respiration | 1 | 2021 | 1653 | 0.030 |
Why?
|
| Static Electricity | 1 | 2015 | 267 | 0.030 |
Why?
|
| Cyclodextrins | 1 | 2014 | 57 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 20822 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2018 | 687 | 0.030 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2014 | 44 | 0.030 |
Why?
|
| Capsules | 1 | 2014 | 196 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2016 | 768 | 0.030 |
Why?
|
| Vimentin | 1 | 2014 | 261 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 393 | 0.030 |
Why?
|
| Macrolides | 1 | 2015 | 201 | 0.030 |
Why?
|
| Microscopy | 1 | 2019 | 903 | 0.030 |
Why?
|
| Lipids | 2 | 2015 | 3305 | 0.030 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2018 | 933 | 0.030 |
Why?
|
| Chloroquine | 1 | 2015 | 280 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2018 | 1539 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 898 | 0.030 |
Why?
|
| Virus Replication | 1 | 2021 | 2534 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2021 | 1058 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3557 | 0.030 |
Why?
|
| Vaccines, Conjugate | 1 | 2014 | 333 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2015 | 4386 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2016 | 973 | 0.030 |
Why?
|
| Immunity | 1 | 2018 | 1012 | 0.030 |
Why?
|
| Binding Sites | 1 | 2021 | 6114 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2018 | 1172 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2016 | 1470 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2016 | 2234 | 0.020 |
Why?
|
| Female | 6 | 2021 | 380194 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2016 | 3689 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 526 | 0.020 |
Why?
|
| Wound Healing | 1 | 2021 | 2785 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2014 | 1899 | 0.020 |
Why?
|
| Lung | 2 | 2021 | 9856 | 0.020 |
Why?
|
| Cell Death | 1 | 2015 | 1706 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2015 | 710 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1970 | 0.020 |
Why?
|
| Cell Movement | 1 | 2021 | 5217 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3870 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2015 | 828 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2021 | 6196 | 0.020 |
Why?
|
| Ligands | 1 | 2014 | 3282 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 3508 | 0.020 |
Why?
|
| Intestines | 1 | 2015 | 1924 | 0.020 |
Why?
|
| Skin | 1 | 2018 | 4364 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 19905 | 0.020 |
Why?
|
| Software | 1 | 2019 | 4443 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18029 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 4479 | 0.010 |
Why?
|
| Cytokines | 1 | 2015 | 7322 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 12072 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 13881 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 63114 | 0.010 |
Why?
|
| Male | 1 | 2016 | 350118 | 0.000 |
Why?
|
Concepts
(211)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_